IN NEW YORK STATE, 26.9% OF MEDICARE-AGED PATIENTS WHO RECEIVED FAUCI'S 5-DAY REMDESIVIR
IN NEW YORK STATE, 26.9% OF MEDICARE-AGED PATIENTS WHO RECEIVED FAUCI'S 5-DAY REMDESIVIR

IN NEW YORK STATE, 26.9% OF MEDICARE-AGED PATIENTS WHO RECEIVED FAUCI'S 5-DAY REMDESIVIR PROTOCOL DIED.